LLY

912.05

-2.04%↓

UNH

557.77

-8%↓

NVO

117.83

-1.6%↓

JNJ

164.1

+1.3%↑

ABBV

191.67

-2.18%↓

LLY

912.05

-2.04%↓

UNH

557.77

-8%↓

NVO

117.83

-1.6%↓

JNJ

164.1

+1.3%↑

ABBV

191.67

-2.18%↓

LLY

912.05

-2.04%↓

UNH

557.77

-8%↓

NVO

117.83

-1.6%↓

JNJ

164.1

+1.3%↑

ABBV

191.67

-2.18%↓

LLY

912.05

-2.04%↓

UNH

557.77

-8%↓

NVO

117.83

-1.6%↓

JNJ

164.1

+1.3%↑

ABBV

191.67

-2.18%↓

LLY

912.05

-2.04%↓

UNH

557.77

-8%↓

NVO

117.83

-1.6%↓

JNJ

164.1

+1.3%↑

ABBV

191.67

-2.18%↓

Strona główna・Stock List・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Closed

Sector Healthcare

341.22 2.15

Buy Sell

Overview

Share price change

24h

Current

Min

333.13

Max

342.19

Key metrics
By Trading Economics
Income	-2.5B -2.2B
Sales	28M 639M
EPS	3.11
Profit margin	-339.153
Employees	8,030
EBITDA	-3.3B -2.7B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+11.1 upside

Dividends
By Dow Jones
Next Earnings	24 paź 2024

Market Stats
By TradingEconomics
Market Cap	312M 9.7B
Previous open	339.07
Previous close	341.22

News Sentiment

By Acuity

50%

174 / 366 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

339.45 / 343.97 Support & Resistance

Bio-Rad Laboratories Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 paź 2024, 18:15 UTC

Acquisitions, Mergers, Takeovers

Accenture Acquires Supply Chain Consulting Firm Joshua Tree Group

14 paź 2024, 23:51 UTC

Market Talk

Gold Steady, Supported by Geopolitical Tensions in Asia -- Market Talk

14 paź 2024, 22:40 UTC

Market Talk

Australian Lithium Miners Tipped for Mixed Production Results -- Market Talk

14 paź 2024, 22:30 UTC

Market Talk

Netflix to Continue Leaning Into Streamflation -- Market Talk

14 paź 2024, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

14 paź 2024, 22:20 UTC

Market Talk

Sandfire Rally Too Hot, According to One Former Bull -- Market Talk

14 paź 2024, 21:49 UTC

Market Talk

Pantoro's Investment Case Bolstered by Solid Quarter -- Market Talk

14 paź 2024, 21:19 UTC

Acquisitions, Mergers, Takeovers

Young Poong-MBK Consortium Previously Sought Controlling Stake of Up to 47.7%

14 paź 2024, 21:19 UTC

Acquisitions, Mergers, Takeovers

Young Poong Has Teamed Up With Private Equity Firm, MBK Partners, to Seek Control of Korea Zinc

14 paź 2024, 21:19 UTC

Acquisitions, Mergers, Takeovers

Young Poong's Total Stake Set to Rise to 38.44% in Korea Zinc

14 paź 2024, 21:18 UTC

Acquisitions, Mergers, Takeovers

Young Poong Secures Additional 5.34% Stake in Korea Zinc via Latest Tender Offer

14 paź 2024, 21:08 UTC

Earnings

Boeing Stock Fell. Why Analysts Are Still Backing Shares. -- Barrons.com

14 paź 2024, 20:51 UTC

Top News

Nvidia Stock Tops Its Record. What's Driving Shares Higher. -- Barrons.com

14 paź 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

14 paź 2024, 20:12 UTC

Top News

Nasdaq Leads Gains; Dow Closes Above 43000 -- WSJ

14 paź 2024, 20:00 UTC

Top News

Fed's Waller Makes the Case for a Slower Pace of Rate Cuts -- Barrons.com

14 paź 2024, 19:32 UTC

Market Talk

Oil Futures Lose Ground on Demand Concerns -- Market Talk

14 paź 2024, 19:28 UTC

Market Talk

U.S. Natural Gas Falls, Waiting for Weather to Turn -- Market Talk

14 paź 2024, 19:26 UTC

Top News

Google Backs New Nuclear Plants to Power AI -- Update

14 paź 2024, 18:29 UTC

Market Talk

Inflow Inches Higher for Gold -- Market Talk

14 paź 2024, 18:07 UTC

Top News

Nasdaq Leads Gains, Crude Prices Down -- WSJ

14 paź 2024, 17:52 UTC

Acquisitions, Mergers, Takeovers

Accenture Didn't Disclose Terms of Deal for Franklin, Tenn.-Based Joshua Tree >ACN

14 paź 2024, 17:52 UTC

Acquisitions, Mergers, Takeovers

Accenture Buys Supply-Chain Consulting Firm Joshua Tree Group >ACN

14 paź 2024, 17:43 UTC

Earnings

Bitcoin's Jump Is Boosting MicroStrategy and Other Crypto Stocks. Be Careful. -- Barrons.com

14 paź 2024, 16:32 UTC

Market Talk

Global Equities Roundup: Market Talk

14 paź 2024, 16:32 UTC

Market Talk

Boeing Has Bumpy Road To Recovery -- Market Talk

14 paź 2024, 16:21 UTC

Top News

Nasdaq Leads Gains, Crude Prices Decline -- WSJ

14 paź 2024, 16:16 UTC

Market Talk

Inflation Expected To Remain At Target Or Higher -- Market Talk

14 paź 2024, 16:12 UTC

Acquisitions, Mergers, Takeovers

Saint-Gobain Didn't Disclose Financial Details

14 paź 2024, 16:12 UTC

Acquisitions, Mergers, Takeovers

Saint-Gobain: Transaction Is Subject to Customary Closing Conditions

Peer Comparison

Price change

Bio-Rad Laboratories Inc Forecast

Price Target

By TipRanks

11.1% upside

12 Months Forecast

Average 374.33 USD 11.1%

High 401 USD

Low 315 USD

Based on 6 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Bio-Rad Laboratories Inc - Dist in the past 3 months.

Technical Score

By Trading Central

339.45 / 343.97Support & Resistance

Recent bullish events outweigh bearish events.

All events are bullish.

Bullish events outweigh bearish events.

Sentiment

By Acuity

174 / 366 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.